Federal contract award
75N95019F00088
THE PURPOSE OF THE TO REQUIREMENT IS TO CONDUCT A PHASE I STUDY OF CBD-MORPHINE DRUG-DRUG INTERACTION. TRI HAS CLEARLY DEFINED THE OBJECTIVES OF THE TO IN THEIR PROPOSAL SUBMISSION.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIDA |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | AN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH |
| Parent award / vehicle | 75N95019D00009 |
| Set-aside | Not reported |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $268.7K |
| Current contract value | $268.7K |
| Potential contract value / ceiling | $268.7K |
| Start date | Sep 20, 2019 |
| Current end date | Sep 19, 2024 |
| Potential end date | Sep 19, 2024 |
| Latest award activity | Jun 18, 2024 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 5 of 5 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jun 18, 2024 | P00004 | $55.7K | PHARMACOKINETIC ANALYSIS RESOURCE CENTER. PHASE 1 STUDY OF CBD-MORPHINE DRUG-DRUG INTERACTION. 09/20/2019 - 09/19/2024. |
| Apr 11, 2024 | P00003 | $33.1K | CHANGES. PHARMACOKINETIC ANALYSIS RESOURCE CENTER. PHASE 1 STUDY OF CBD-MORPHINE DRUG-DRUG INTERACTION. 09/20/2019 - 09/19/2024. |
| Aug 23, 2022 | P00002 | $0 | THE PURPOSE OF THE MODIFICATION IS TO EXTEND THE PERIOD OF PERFORMANCE FOR TASK ORDER NO. 75N95019F00088 UNTIL SEPTEMBER 19, 2024 AT NO ADDITIONAL COST OR FEE. |
| Mar 17, 2021 | P00001 | $0 | THE PURPOSE OF THE MODIFICATION IS TO EXTEND THE PERIOD OF PERFORMANCE FOR TASK ORDER NO. 75N95019F00088 UNTIL SEPTEMBER 20, 2022 AT NO ADDITIONAL COST OR FEE. |
| Sep 20, 2019 | 0 | $179.9K | THE PURPOSE OF THE TO REQUIREMENT IS TO CONDUCT A PHASE I STUDY OF CBD-MORPHINE DRUG-DRUG INTERACTION. TRI HAS CLEARLY DEFINED THE OBJECTIVES OF THE TO IN THEIR PROPOSAL SUBMISSION. |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.